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which was performed in two of their patients.Wewould like to elab-
orate on the coil embolization of dissecting aneurysms.
There are many articles reporting the endovascular treatment of
SIDSMA in recent years; many patients with dissecting aneurysms
were treated by placement of self-expandable and open stents without
coil embolization, andall of themwere discharged uneventfully.2-4We
believe that the dissecting aneurysm would thrombose and that the
aneurysm size would be reduced after placement of a stent, with
gradual resolution of the false lumen and improved remodeling with
patencyof the true lumen.There likely exists a risk of ruptureof thedis-
secting aneurysmwith placement of coils, and the true lumenmay also
be compressed if coils are used. Although the authors have a good
result after coil embolization of the dissecting aneurysm in two pa-
tients, we think it may not be necessary to perform such embolization.
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study of the Ovation abdominal stent graft system for
endovascular aneurysm repair”
It was a great pleasure to read the article by Mehta et al,1 who
reported for the ﬁrst time in the literature the 1-year outcomes of
the Ovation trimodular stent graft system. The authors reported a
technical success of 100%, with no stent graft migration or type I,
III, or IV endoleaks.
Interestingly, according to the demonstrated patient charac-
teristics, the maximum diameters of the treated aneurysms were
54 6 9 mm, whereas the juxtarenal neck angulation was mild or
moderate: 19 6 14. Therefore, it could be noted that these char-
acteristics describe an aneurysm study group of limited difﬁculty, in
which the anticipated technical challenges in deployment and iliac
gate catheterization of the endograft are easily managed. However,
our personal experience with the Ovation device dictates that when
managing larger aneurysms with/or greater neck angulation,
certain procedural difﬁculties can be encountered because of its
structural differences compared with other devices.2
The Ovation device is a trimodular prosthesis comprising a
nitinol-unsupported polytetraﬂuoroethylene main body and two
limb gates with inﬂatable rings that are simultaneously released
freely in the aortic lumen.1 Because the ipsilateral limb is neither
ﬁxed nor contained within the iliac tract by the time of the main
body unsheathing, we have frequently observed an antero-
posterior accommodation of the limb gates rather than the morecommon side-by-side limb conﬁguration of other bimodular stent
grafts, thus rendering the cannulation of the contralateral limb chal-
lenging and often leading to the cross-limb conﬁguration (as Fig 3,
B suggests), that is, a technique prolonging the procedural time.3
On the basis of the aforementioned information, it would be
interesting to note if the cross-limb technique was performed or
whether any additional maneuvers were used to facilitate the
contralateral limb catheterization.4 Furthermore, because the au-
thors report successful management of aneurysms with challenging
anatomy (63 patients, among whom 13 had an aortic neck length
of #10 mm and 11 more had a neck length of <10 mm and iliac
diameter of <6 mm), it would be interesting to have their feedback
on the procedural duration, ﬂuoroscopy time, and amount of
contrast, comparing the aneurysms of challenging anatomy with
the those of typical anatomy (98 patients).
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On behalf of the Ovation pivotal trial investigators, I much
appreciate the opportunity to respond to the insightful letter
from Prof Georgakarakos and colleagues.
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878 Letters to the Editor March 2014The primary aim of our study1 was to evaluate the safety and
efﬁcacy of the Ovation stent graft system, and the maximum diam-
eter of the treated abdominal aortic aneurysm (AAA) (546 9 mm)
and the aortic neck angulation (19 6 14) were very similar with
other pivotal AAA stent graft trials (Excluder, Endurant, Zenith,
etc). In addition to the standard anatomy group, there was an
additional anatomically challenging subgroup of patients which
had similar outcomes to the standard group.
Prof Georgakarakos and colleagues indicate that in their expe-
rience, the contralateral limb cannulation could be challenging
with the Ovation stent graft, as the contralateral gate is not ﬁxed
to the ipsilateral side and on deployment can shift into the
antero-posterior position. In the current version of the Ovation
stent graft system, the contralateral leg is tethered to the ipsilateral
main catheter, which facilitates device orientation as well as gate
cannulation. It is only after contralateral gate cannulation, com-
plete stent graft deployment, and main catheter disconnection
that this tether is released. Since there are many variables that ac-
count for contralateral gate cannulation, including complex anat-
omy and operator experience, we did not collect data on the
cannulation times. The overall procedure times were substantially
lower than what has been previously reported in other pivotal tri-
als; the mean total procedure time was 110 minutes (range, 46-
264 minutes; standard deviation, 41.4 minutes). Although data
were not collected on cross-limb techniques, it is my personal
belief that limb-crossing based on contralateral sheath orientation
within the AAA sac is beneﬁcial in reducing gate cannulation times;
in our practice, >80% of patients have stent graft limbs crossed
during endovascular aneurysm repair, regardless of device.In comparing patients with challenging anatomy to the
entire cohort, there were no signiﬁcant differences in the median
procedure time (98 minutes vs 105 minutes), ﬂuoroscopic times
(22 minutes vs 21 minutes), or the amount of contrast used
(130 mL vs 132 mL). Furthermore, the major adverse event rates
were comparable in patients with challenging anatomy (3% [2 of
63]) compared with those with typical anatomy (4% [6 of 98]).
All patients with challenging anatomy achieved treatment success,
and AAA-related secondary procedures were comparable and
performed in 3% of patients with challenging anatomy compared
with 8% of those with typical anatomy.
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